KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$27.8 million.

  • Biogen's Change in Receivables rose 7064.41% to -$27.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$102.7 million, marking a year-over-year increase of 5380.12%. This contributed to the annual value of -$102.7 million for FY2025, which is 5380.12% up from last year.
  • As of Q4 2025, Biogen's Change in Receivables stood at -$27.8 million, which was up 7064.41% from -$245.4 million recorded in Q3 2025.
  • Over the past 5 years, Biogen's Change in Receivables peaked at $181.0 million during Q1 2025, and registered a low of -$245.4 million during Q3 2025.
  • Over the past 5 years, Biogen's median Change in Receivables value was -$24.0 million (recorded in 2022), while the average stood at -$25.4 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first crashed by 67335.53% in 2021, then soared by 51418.76% in 2025.
  • Quarter analysis of 5 years shows Biogen's Change in Receivables stood at -$167.0 million in 2021, then surged by 156.23% to $93.9 million in 2022, then crashed by 246.75% to -$137.8 million in 2023, then soared by 31.28% to -$94.7 million in 2024, then surged by 70.64% to -$27.8 million in 2025.
  • Its Change in Receivables stands at -$27.8 million for Q4 2025, versus -$245.4 million for Q3 2025 and -$10.5 million for Q2 2025.